Navigation Links
Celebrex Plus Lipitor Could Fight Prostate Cancer
Date:4/14/2008

Combining painkiller with statin slows tumor progression, mouse study suggests

MONDAY, April 14 (HealthDay News) -- Two widely used drugs -- one lowers cholesterol and one is an anti-inflammatory -- may be useful in controlling prostate cancer.

New research being presented at the American Association for Cancer Research annual meeting in San Diego finds that the painkiller Celebrex and the statin Lipitor, when used together or alone, can stop early prostate cancer before it becomes deadly.

The study was conducted in mice so the idea isn't yet ready for clinical use, but experts said these preliminary results did look promising.

"They need to come up with the molecular mechanics and then take it back to clinical trials," said Dr. K. Scott Coffield, a professor of surgery at Texas A&M Health Science Center College of Medicine and a urologist-oncologist at Scott & White. "It's early but it's interesting and that's wonderful."

"It's very intriguing and it gives some clinical data, but it's not enough to start recommending these medications for people who don't need them for other reasons," added Dr. Ronald D. Ennis, director of radiation oncology at St. Luke's Roosevelt Hospital, Continuum Cancer Centers, in New York City.

Prostate cancer is the second-leading cancer killer in men in the United States. In the early stages, prostate tumors depend on androgen (male) hormones such as testosterone to grow. As such, early treatment typically involves interfering with these hormones but these therapies eventually lose their effectiveness. Tumors that are dependent on androgen are typically less aggressive than later tumors that don't rely on androgen.

Epidemiological studies have suggested that statins (such as Lipitor) and nonsteroidal anti-inflammatory drugs (such as Celebrex) may be able to stop the progression from an early cancer to a later, more aggressive malignancy.

Th
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Celebrex-Lipitor combo may halt prostate cancer
2. Statement of Robert Jarvik, MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. HIV denialists spread misinformation online -- consequences could be deadly; and more
6. Virus Could Help Drive Obesity
7. Discovery of sugar sensor in intestine could benefit diabetes
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
10. High-risk behaviors could lead to HIV epidemic in Afghanistan
11. Chinas 1-child policy could backfire on its elderly
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Celebrex Plus Lipitor Could Fight Prostate Cancer
(Date:9/18/2014)... WA (PRWEB) September 18, 2014 Kent, ... Lake Meridian Chiropractic are pleased to announce that Dawn Kelly ... 24-year-old clinic. Dr. Saggau looks forward to Ms. Kelly ... and administrative talents will make her a key contributor. ... combination of educational, professional, and personal experiences that will ...
(Date:9/18/2014)... Dr. David A. F. Ellis is a Board ... Facial Plastic and Reconstructive Surgery and a Professor at ... Plastic Surgery. He is recognized around the world ... Dr. Ellis will be presenting on numerous injectable topics. ... techniques and various treatments for complications associated with injectable ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Alexandria, VA ... announced today that 10 more communities have joined the ... public health department accreditation. The decisions bring the number ... to 54. PHAB is the non-profit organization that administers ... improve and protect the health of the public by ...
(Date:9/18/2014)... -- Exposure to diverse communities may boost infants, social ... different languages in the park or supermarket could help ... who are different from them, researchers found. ... biased against interacting with and learning from people who ... of Chicago psychology professor, said in a university news ...
(Date:9/18/2014)... Sept. 18, 2014 (HealthDay News) -- Older people become ... That,s because the balance of stress hormones during bereavement ... older people who are grieving are more likely to ... found. "During the difficult weeks and months after ... are the most abundant type of white blood cell ...
Breaking Medicine News(10 mins):Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Dr. David A. F. Ellis Has Been Invited to Speak at a Conference of the American Academy of Facial Plastic and Reconstructive Surgery in Orlando, Florida 2Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2
... identified a particular combination of health problems that can ... three-fold increase in the risk of mortality. , The ... at Warwick Medical School Dr Oscar Franco, has discovered ... blood sugar are the most dangerous combination of health ...
... ... hospice care to families throughout the San Francisco Bay Area. , ... Walnut Creek, CA (PRWEB) November 2, ... and personal caregiver services in Northern California, has announced the expansion of its services ...
... Video, "Waitin, Room Service" , WASHINGTON, Nov. 2 Lung ... will launch a new public service campaign aimed at creating ... http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ) , Dr. Lung Love, a versatile, multi-genre ... Room Service" which is being launched today. , ...
... KENILWORTH, N.J., Nov. 2 Schering-Plough Corporation (NYSE: ... two projects in India to reduce the incidence of ... mass vaccination of dogs. The company will donate $200,000 ... expertise with partners to support successful implementation of the ...
... ... "Leadership in Innovation" Award Winner Patrick Soon-Shiong, MD, Chairman and CEO of Abraxis Health, ... in HealthcareSM Awards Event this week. They were: Dakim, Inc.; Epocrates, Inc.; and Osmetech ... ...
... ... the release of the Office of the National Coordinator for Health Information Technology (ONC) requirements ... by numerous EHR software and services companies that need to be certified. , ... Fort Worth, TX (PRWEB) November 2, 2009 ...
Cached Medicine News:Health News:Researchers identify the 3 killer indicators that are even worse than high cholesterol 2Health News:Professional HealthCare at Home Expands Services to Provide Licensed Hospice Care in Northern California 2Health News:Lung Cancer Alliance Announces New National Campaign Starring Dr. Armando Lung Love 2Health News:Schering-Plough Announces Sponsorship of Rabies-Control Projects in India 2Health News:Schering-Plough Announces Sponsorship of Rabies-Control Projects in India 3Health News:Schering-Plough Announces Sponsorship of Rabies-Control Projects in India 4Health News:Schering-Plough Announces Sponsorship of Rabies-Control Projects in India 5Health News:Patrick Soon-Shiong, MD, and Three Healthcare Companies Win 2009 Innovations in Healthcare Awards 2Health News:Patrick Soon-Shiong, MD, and Three Healthcare Companies Win 2009 Innovations in Healthcare Awards 3Health News:Patrick Soon-Shiong, MD, and Three Healthcare Companies Win 2009 Innovations in Healthcare Awards 4Health News:Drummond Group Plans to Certify Electronic Health Records 2Health News:Drummond Group Plans to Certify Electronic Health Records 3
(Date:9/18/2014)... LA JOLLA, Calif. , Sept. 18, 2014 ... RGLS ), a biopharmaceutical company leading the ... announced today it has initiated its ATHENA natural ... syndrome, a life-threatening genetic kidney disease with no ... characterize the natural decline of renal function markers ...
(Date:9/18/2014)... and ROCKVILLE, Md. , ... SPPI ), a biotechnology company with fully integrated ... in hematology and oncology, and CASI Pharmaceuticals, Inc. (Nasdaq: ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a primary focus on China ...
(Date:9/18/2014)... 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies ... technologies, today announced that the Company,s President and ... , will present at the 7 th ... September 24, 2014 at 11:20 a.m. EDT.  ...
Breaking Medicine Technology:Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 3Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 4Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 5Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 7Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 8Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 9Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 10RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3
Enzyme Immunoassay of -Thromboglobulin Antigen by ELISA Method, 96 tests....
Calibration plasmas for Assays of Low Molecular Weight Heparins (LMWH)using the Anti-Xa method on STA© Analyzers....
Multi-constituent Calibration Plasma for Functional Assays of Coagulation Parameters on STA© Analyzers....
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
Medicine Products: